Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Therapeutic Advances in Medical Oncology|December 22, 2022
Combatting acquired resistance to osimertinib in EGFR-mutant lung cancerJiyun Lee, Zofia Piotrowska, Ross Soo, et al.
JCO Oncology Practice|September 21, 2023
Path Less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung CancerSun Min Lim, Jii Bum Lee, Yuko Oya, et al.
Oncotarget|October 1, 2016
Immune adjuvant effect of a Toxoplasma gondii profilin-like protein in autologous whole-tumor-cell vaccination in miceKyoung-Ho Pyo, You-Won Lee, Sun Min Lim, et al.
Cancer Treatment Reviews|February 26, 2018
Acquired resistance to EGFR targeted therapy in non-small cell lung cancer: Mechanisms and therapeutic strategiesSun Min Lim, Nicholas L Syn, Byoung Chul Cho, et al.
Lung Cancer (Amsterdam, Netherlands)|June 11, 2020
AXL/MET dual inhibitor, CB469, has activity in non-small cell lung cancer with acquired resistance to EGFR TKI with AXL or MET activationYu-Mi Yang, Yoon Jang, Sang Hyuk Lee, et al.
JTO Clinical and Research Reports|September 30, 2021
Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and SavolitinibSun Min Lim, San-Duk Yang, Sangbin Lim, et al.
Yonsei Medical Journal|October 27, 2011
Fever-induced QTc prolongation and ventricular fibrillation in a healthy young manSun Min Lim, Hui-Nam Pak, Moon-Hyoung Lee, et al.
Yonsei Medical Journal|September 21, 2019
Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung CancerSeungtaek Lim, Sun Min Lim, Min Ju Kim, et al.
Future Oncology (London, England)|March 9, 2013
Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinomaSun Min Lim, Hye Ryun Kim, Hyo Sup Shim, et al.
Therapeutic Advances in Medical Oncology|February 9, 2023
Advances in the management of non-small-cell lung cancer harbouring <i>EGFR</i> exon 20 insertion mutationsJia Li Low, Sun Min Lim, Jii Bum Lee, et al.
Pageof 14